Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?

Current Pharmaceutical Design - United Arab Emirates
doi 10.2174/138161210790361461
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Population Shift Mechanism for Partial Agonism of AMPA Receptor

Biophysical Journal
Biophysics
2019English

Partial Agonism and Antagonism of the Ionotropic Glutamate Receptor iGLuR5

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Third-Generation Mineralocorticoid Receptor Antagonists

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2016English

Review: New Generation Antipsychotic Drugs May Reduce Relapse Rates More Effectively Than Conventional Antipsychotic Drugs in People With Schizophrenia

Evidence-Based Mental Health
PsychiatryMental Health
2004English

Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2015English

Correction to “A Scale of Agonism and Allosteric Modulation for Assessment of Selectivity, Bias, and Receptor Mutation”

Molecular Pharmacology
Molecular MedicinePharmacology
2017English

Implications of Amylin Receptor Agonism

Archives of Neurology
2009English

Concomitant Use of Two or More Antipsychotic Drugs Is Common in Sweden

Therapeutic Advances in Psychopharmacology
2015English

Menstrual Changes With Antipsychotic Drugs

British Journal of Psychiatry
MedicinePsychiatryMental Health
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy